Ranganath Muniyappa, M.D., Ph.D.
Photo of Ranganath Muniyappa
Scientific Focus Areas: Cell Biology, Clinical Research, Health Disparities


A selection of recent and significant publications can be viewed below.

Personalized Statin Therapy and Coronary Atherosclerotic Plaque Burden in Asymptomatic Low/Intermediate-Risk Individuals.
Muniyappa R, Noureldin RA, Abd-Elmoniem KZ, El Khouli RH, Matta JR, Hamimi A, Ranganath S, Hadigan C, Nieman LK, Gharib AM.
Cardiorenal Med (2018) 8:140-150. Abstract/Full Text
Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women.
Muniyappa R, Sullivan SD, Tella SH, Abel BS, Harman SM, Blackman MR.
Physiol Rep (2017 Dec) 5. Abstract/Full Text
Plasma serpinB1 is related to insulin sensitivity but not pancreatic β-Cell function in non-diabetic adults.
Glicksman M, Asthana A, Abel BS, Walter MF, Skarulis MC, Muniyappa R.
Physiol Rep (2017 Mar) 5. Abstract/Full Text
Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.
Muniyappa R, Abel BS, Asthana A, Walter MF, Cochran EK, Remaley AT, Skarulis MC, Gorden P, Brown RJ.
J Clin Lipidol (2017 Mar - Apr) 11:543-550. Abstract/Full Text
Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients.
Levenson AE, Haas ME, Miao J, Brown RJ, de Ferranti SD, Muniyappa R, Biddinger SB.
Endocrinology (2016 Apr) 157:1421-9. Abstract/Full Text